Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes.
Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes.
复制标题
DOI:
10.1186/s13293-022-00417-3
复制
发表时间:
2022-03-04
影响因子:
7.9
通讯作者:
Monte AA
中科院分区:
文献类型:
--
作者:
Arnold CG;Libby A;Vest A;Hopkinson A;Monte AA
Although biological males and females are equally likely to become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evidence has mounted that males experience higher severity and fatality compared to females. The objective of this review is to examine the existing literature on biological mechanisms underlying sex-based differences that could contribute to SARS-CoV-2 infection clinical outcomes. Sex-based differences in immunologic response and hormonal expression help explain the differences in coronavirus disease 2019 (COVID-19) outcomes observed in biological males and females. X inactivation facilitates a robust immune response to COVID-19 in females, who demonstrate a more profound antibody response and faster recovery when compared to males. Low testosterone levels also help explain the dysregulated inflammatory response and poor outcomes observed in some males with COVID-19. Gender differences in health expression and behaviors further compound these observed differences. Understanding the biology of sex-based differences in COVID-19 severity and mortality could help inform preventative measures, treatment decisions, and development of personalized, sex-specific therapies. Although most COVID-19 patients develop only mild disease, some mount a pronounced inflammatory response that results in severe pneumonia, respiratory failure, and death. Male sex is a known risk factor for severe outcomes in COVID-19. Biological sex-based differences in COVID-19 severity and mortality are influenced by genetic and hormonal differences at the cellular and immunologic level. Biological sex-based differences are further complicated by environmental factors, namely social and cultural norms, that define gender roles which impact risk of infection and severe outcomes. Understanding sex-based differences in COVID-19 outcomes will help inform clinical decision algorithms and treatment strategies to optimize the care of COVID-19 patients.
登录
查看更多内容
DOI:
10.15585/mmwr.mm6942e1
发表时间:
2020-10-23
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Gold JAW;Rossen LM;Ahmad FB;Sutton P;Li Z;Salvatore PP;Coyle JP;DeCuir J;Baack BN;Durant TM;Dominguez KL;Henley SJ;Annor FB;Fuld J;Dee DL;Bhattarai A;Jackson BR
通讯作者:
Jackson BR
影响因子:
3.7
作者:
Huang B;Cai Y;Li N;Li K;Wang Z;Li L;Wu L;Zhu M;Li J;Wang Z;Wu M;Li W;Wu W;Zhang L;Xia X;Wang S;Chen H;Wang Q
通讯作者:
Wang Q
DOI:
10.4049/jimmunol.1601896
发表时间:
2017-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Channappanavar R;Fett C;Mack M;Ten Eyck PP;Meyerholz DK;Perlman S
通讯作者:
Perlman S
影响因子:
12.7
作者:
Meerwijk, Esther L.;Sevelius, Jae M.
通讯作者:
Sevelius, Jae M.
DOI:
10.1056/nejmp2023616
发表时间:
2020-09-17
期刊:
The New England journal of medicine
影响因子:
--
作者:
Egede LE;Walker RJ
通讯作者:
Walker RJ